Alpha Cognition Inc. (ACOG)
(Delayed Data from NSDQ)
$9.09 USD
+0.35 (4.00%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $9.07 -0.02 (-0.22%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ACOG 9.09 +0.35(4.00%)
Will ACOG be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ACOG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACOG
What Makes Alpha Cognition Inc. (ACOG) a New Strong Buy Stock
Is Alpha Cognition Inc. (ACOG) Outperforming Other Medical Stocks This Year?
ACOG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should You Buy Alpha Cognition Inc. (ACOG) After Golden Cross?
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Misses Revenue Estimates
Other News for ACOG
Alpha Cognition to Report Second Quarter 2025 Financial Results and Operating Overview | ACOG ...
Alpha Cognition: Unheralded Canadian Pharma Set To Launch Alzheimer's Drug
Alpha Cognition announces CMS Zunveyl NDA accepted for review by NMPA
Alpha Cognition (ACOG) Seeks Approval for Alzheimer's Drug in China